Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808665-21-000054
Filing Date
2021-05-24
Accepted
2021-05-24 17:05:20
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162189030058841.html 4  
1 FORM 4 wf-form4_162189030058841.xml 4 3108
  Complete submission text file 0001808665-21-000054.txt   4538
Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Peisert Daniel A. (Reporting) CIK: 0001758376 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39294 | Film No.: 21955914

Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Issuer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations